July 10, 2013 U.S. Food and Drug Administration and European Medicines Agency Reach Landmark Decisions on Critical Path Institute’s Clinical Trial Simulation Tool for Alzheimer’s Disease
July 1, 2013 Alzheimer’s Disease Public-Private Partnerships: A Landscape of the Global Nonprofit Community
